EUDAMED is scheduled to be ‘fully functional’ sometime in Q2 2024. This means that all six modules of EUDAMED have been built out and EUDAMED as a whole has passed an independent audit. It would then be published in the Official Journal of the European Union (OJEU). After publication in the OJEU, the 6-24 month transition period begins.
There is a six-month transition period for the following modules: Actor, Vigilance, Clinical Investigation & Performance Studies and Market Surveillance. There is a 24-month transition period for the following modules: UDI/Device and Notified Body & Certificates modules.